Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities

EOJ Porta, K Kalesh, PG Steel - Frontiers in pharmacology, 2023 - frontiersin.org
Chagas disease is a vector-borne illness caused by the protozoan parasite Trypanosoma
cruzi (T. cruzi). It poses a significant public health burden, particularly in the poorest regions …

Current landscape of methods to evaluate antimicrobial activity of natural extracts

R Gonzalez-Pastor, SE Carrera-Pacheco… - Molecules, 2023 - mdpi.com
Natural extracts have been and continue to be used to treat a wide range of medical
conditions, from infectious diseases to cancer, based on their convenience and therapeutic …

Chagas disease: perspectives on the past and present and challenges in drug discovery

FRP Mansoldo, F Carta, A Angeli, VS Cardoso… - Molecules, 2020 - mdpi.com
Chagas disease still has no effective treatment option for all of its phases despite being
discovered more than 100 years ago. The development of commercial drugs has been …

Review of pharmacological options for the treatment of Chagas disease

F Lascano, F García Bournissen… - British journal of clinical …, 2022 - Wiley Online Library
Chagas disease (CD) is a worldwide problem, with over 8 million people infected in both
rural and urban areas. CD was first described over a century ago, but only two drugs are …

Of drugs and trypanosomatids: new tools and knowledge to reduce bottlenecks in drug discovery

A Bhattacharya, A Corbeil, RL do Monte-Neto… - Genes, 2020 - mdpi.com
Leishmaniasis (Leishmania species), sleeping sickness (Trypanosoma brucei), and Chagas
disease (Trypanosoma cruzi) are devastating and globally spread diseases caused by …

Targeting Metalloenzymes: The “Achilles' Heel” of Viruses and Parasites

D Moianos, GM Prifti, M Makri, G Zoidis - Pharmaceuticals, 2023 - mdpi.com
Metalloenzymes are central to the regulation of a wide range of essential viral and parasitic
functions, including protein degradation, nucleic acid modification, and many others. Given …

Animal models of Chagas disease and their translational value to drug development

E Chatelain, I Scandale - Expert Opinion on Drug Discovery, 2020 - Taylor & Francis
Introduction American trypanosomiasis, better known as Chagas disease, is a global public
health issue. Current treatments targeting the causative parasite, Trypanosoma cruzi, are …

The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-an update from 2012 to 2021

H Barbosa, F Thevenard… - Current Topics in …, 2023 - ingentaconnect.com
Background: Chagas disease (American Trypanosomiasis) is classified by the World Health
Organization (WHO) as one of the seventeen neglected tropical diseases (NTD), affecting …

Selenium as an interesting option for the treatment of Chagas disease: A review

V Alcolea, S Pérez-Silanes - European journal of medicinal chemistry, 2020 - Elsevier
Chagas disease is one of the most prevalent tropical neglected diseases and causes high
mortality and morbidity in endemic countries. Current treatments for this disease, nifurtimox …

Accuracy of diagnostic tests for the detection of Chagas disease: A systematic review and meta-analysis

MA Candia-Puma, LY Machaca-Luque… - Diagnostics, 2022 - mdpi.com
The present systematic review and meta-analysis about the accuracy of diagnostic tests aim
to describe the findings of literature over the last thirty years for the diagnosis of Chagas …